The success of Viagra initially fueled a surge for pharma, however recent shifts present a uncertain scenario for shareholders. Generic alternatives are reducing revenue, and persistent legal battles add further https://anitapkkg590988.imblogs.net/91013853/sildenafil-and-pharma-a-risky-investment